Elevated levels of the blood markers N-Terminal Pro-B-type Natriuretic Peptide (NT-ProBNP) and cardiac troponin I are additional screening measures that can be performed as they increase with cardiac changes associated with both types of DCM [17, 20]. The gene discussed is NPPB; the disease is familial dilated cardiomyopathy.